219
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease

, ORCID Icon, , , , & show all
Pages 305-316 | Received 20 Aug 2022, Accepted 04 Mar 2023, Published online: 15 Mar 2023

References

  • Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):Itc17–itc32. doi:10.7326/AITC202008040
  • Xu J, Murphy SL, Kockanek KD, Arias E. Mortality in the United States, 2018. NCHS Data Brief. 2020;355:1–8.
  • Wheaton AG, Cunningham TJ, Ford ES, Croft JB. Employment and activity limitations among adults with chronic obstructive pulmonary disease--United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(11):289–295.
  • Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160(11):1683–1689. doi:10.1001/archinte.160.11.1683
  • Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance--United States, 1999–2011. Chest. 2013;144(1):284–305. doi:10.1378/chest.13-0809
  • Gallo M, Sapio L, Spina A, Naviglio D, Calogero A, Naviglio S. Lactic dehydrogenase and cancer: an overview. Front Biosci. 2015;20(8):1234–1249. doi:10.2741/4368
  • Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996;9(8):1736–1742. doi:10.1183/09031936.96.09081736
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
  • Kim D, Konyn P, Cholankeril G, Ahmed A. Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan. Clin Gastroenterol Hepatol. 2022;20(6):e1438–e1455. doi:10.1016/j.cgh.2021.06.029
  • Farhana A, Lappin SL. Biochemistry, lactate dehydrogenase. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC; 2022.
  • Chen J, Sun MX, Hua YQ, Cai ZD. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(7):1205–1210. doi:10.1007/s00432-014-1644-0
  • Li C, Ye J, Chen Q, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging. 2020;12(15):15670–15681. doi:10.18632/aging.103770
  • Xiao Z, Gong R, Chen X, Xiao D, Luo S, Ji Y. Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: a cohort study. J Clin Lab Anal. 2021;35(12):e24049. doi:10.1002/jcla.24049
  • Buckner SL, Loenneke JP, Loprinzi PD. Cross-sectional association between normal-range lactate dehydrogenase, physical activity and cardiovascular disease risk score. Sports Med. 2016;46(4):467–472. doi:10.1007/s40279-015-0457-x
  • Edwards MK, Buckner SL, Loenneke JP, Loprinzi PD. Association between sedentary behavior and normal-range lactate dehydrogenase activity. Postgrad Med. 2017;129(4):484–487. doi:10.1080/00325481.2017.1298390
  • Rumley AG, Pettigrew AR, Colgan ME, et al. Serum lactate dehydrogenase and creatine kinase during marathon training. Br J Sports Med. 1985;19(3):152–155. doi:10.1136/bjsm.19.3.152
  • Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
  • Celli B, Locantore N, Yates JC, et al. Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. Eur Respir J. 2021;57(3):2001339. doi:10.1183/13993003.01339-2020
  • Lonergan M, Dicker AJ, Crichton ML, et al. Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD. Respir Res. 2020;21(1):166. doi:10.1186/s12931-020-01436-7
  • Mannino DM, Valvi D, Mullerova H, Tal-Singer R. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. COPD. 2012;9(4):359–366. doi:10.3109/15412555.2012.668249
  • Tsantes AE, Papadhimitriou SI, Tassiopoulos ST, et al. Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease. Respir Med. 2004;98(11):1117–1123. doi:10.1016/j.rmed.2004.04.002
  • Garcia-Pachon E, Padilla-Navas I. Red cell macrocytosis in COPD patients without respiratory insufficiency: a brief report. Respir Med. 2007;101(2):349–352. doi:10.1016/j.rmed.2006.05.003
  • Castelli R, Bucciarelli P, Porro F, Depetri F, Cugno M. Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality. Thromb Res. 2014;134(2):326–330. doi:10.1016/j.thromres.2014.05.042
  • Skopas V, Papadopoulos D, Trakas N, et al. Lactate dehydrogenase isoenzymes in patients with acute exacerbation of chronic obstructive pulmonary disease: an exploratory cross-sectional study. Respir Physiol Neurobiol. 2021;283:103562. doi:10.1016/j.resp.2020.103562